school for phlebotomist phlebotomy colleges phlebotomy training classes
Thursday, 28 November 2013
New Anti-IL-6 Biologic Succeeds in RA
(MedPage Today) -- The investigational subcutaneous interleukin (IL)-6 blocker sarilumab plus methotrexate was effective in reducing the signs and symptoms of rheumatoid arthritis in a phase III trial, the drug's makers announced Friday. (Source: MedPage Today Geriatrics)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment